Tau oligomers in cerebrospinal fluid in Alzheimer's disease

OBJECTIVE: With an increasing incidence of Alzheimer's disease (AD) and neurodegenerative tauopathies, there is an urgent need to develop reliable biomarkers for the diagnosis and monitoring of the disease, such as the recently discovered toxic tau oligomers. Here, we aimed to demonstrate the p...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Clin Transl Neurol
Autors principals: Sengupta, Urmi, Portelius, Erik, Hansson, Oskar, Farmer, Kathleen, Castillo‐Carranza, Diana, Woltjer, Randall, Zetterberg, Henrik, Galasko, Douglas, Blennow, Kaj, Kayed, Rakez
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2017
Matèries:
Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5376754/
https://ncbi.nlm.nih.gov/pubmed/28382304
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.382
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars